Andrew Holman

Andrew Holman possesses extensive leadership experience in the medical and commercial sectors, currently serving as the Chief Executive Officer of VitalPath. Previously, Holman held the position of Chief Commercial Officer at Prytime Medical Devices, Inc. and BrainScope®. Additionally, Holman served as Global President at QMD - DEGANIA I BIOMETRIX I ARTHESYS and Executive Vice President and Chief Commercial Officer at Integer Holdings Corporation. Holman's educational background includes a College Preparatory degree from St. Xavier High School and studies at Rollins College.